Bristol Myers Squibb has raised its financial forecast for 2026.
The company reported that Eliquis and newer medicines are driving its current results.
Growth in Eliquis and newer medicines drives upward revision of financial outlook.
Talivio News (AI illüstrasyon)
Bristol Myers Squibb has raised its financial forecast for 2026.
The company reported that Eliquis and newer medicines are driving its current results.